A Phase I-II Study of Dasatinib in Combination With Weekly Paclitaxel for Patients With Metastatic Breast Carcinoma.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Dasatinib (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 02 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
- 02 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.